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Abstract
Background: Provider-initiated HIV testing and counselling (PITC) is internationally recommended for tuberculosis (TB)
patients, but the feasibility, effectiveness, and impact of this policy on the TB programme in India are unknown. We
evaluated PITC of TB patients across two districts in India considered to have generalized HIV epidemics, Tiruchirappalli
(population 2.5 million) and Mysore (population 2.8 million).
Methodology/Principal Findings: Starting June 2007, healthcare providers in both districts were instructed to ascertain HIV
status for all TB patients, and refer those with unknown HIV status to the nearest Integrated Counselling and Testing Centre
(ICTC)—often in the same facility—for counselling and voluntary HIV testing. All TB patients registered from June 2007 to
March 2008 were followed prospectively. Field investigators assessed PITC practices and abstracted data from routine TB
programme records and HIV counselling registers to determine the proportion of TB patients appropriately evaluated for
HIV infection. Patient records were traced to determine the efficiency of referral links to HIV care and antiretroviral treatment
(ART). Between July 2007 and March 2008, 5299 TB patients were registered in both study districts. Of the 4701 with
unknown HIV status at the time of TB treatment initiation, 3368 (72%) were referred to an ICTC, and 3111 (66%) were newly
tested for HIV. PITC implementation resulted in the ascertainment of HIV status for 3709/5299 (70%) of TB patients, and
detected 200 cases with previously undiagnosed HIV infection. Overall, 468 (8.8%) of all registered TB patients were HIV-
infected; 177 (37%) were documented to have also received any ART.
Conclusions: With implementation of PITC in India, HIV status was successfully ascertained for 70% of TB patients.
Previously undiagnosed HIV-infection was detected in 6.4% of those TB patients newly tested, enabling referral for life-
saving anti-retroviral treatment. ART uptake, however, was poor, suggesting that PITC implementation should include
measures to strengthen and support ART referral, evaluation, and initiation.
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Introduction
The HIV/AIDS epidemic has increased the global tuberculosis
(TB) burden, and has focused attention on the necessity to closely
coordinate TB and HIV/AIDS control programme services [1].
Early detection of HIV infection among TB patients offers the
opportunity to promptly link patients to HIV care interventions,
such as cotrimoxazole prophylactic treatment (CPT) and antiret-
roviral treatment, which can reduce suffering and death [2].
In India, among the estimated 1.852 million tuberculosis cases
occurring annually, an estimated 5.2%—more than 96,000
persons— are HIV-infected [3]. Surveillance has shown that, in
places where HIV seroprevalence is high, HIV infection among
TB patients is common [4]. Access to HIV counselling, testing,
care and treatment services—including free antiretroviral treat-
ment (ART)—is rapidly expanding under the National AIDS
Control Programme (NACP) [5].
As of 2007, the policy of the Government of India’s Revised
National Tuberculosis Control Programme (RNTCP) and the
National AIDS Control Organization (NACO) was to offer
referral for HIV testing only to those patients with behavioural
risk factors for HIV infection or evidence of opportunistic
infections [6]. This approach proved to be operationally
challenging, as routine ascertainment of HIV behavioural risk
factors in patients or their partners was not always possible due to
crowded outpatient clinical services.
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The World Health Organization (WHO) and Joint United
Nations programme on HIV-AIDS (UNAIDS) now recommend
Provider Initiated HIV Testing and Counselling (PITC) for all TB
patients in all settings [7]. PITC guidelines hold health-care
providers responsible for proactively offering HIV testing and
counselling to all persons with any sign or symptom of HIV infection
or associated opportunistic infections, including tuberculosis.
A study from South India has shown that a majority of TB
patients expressed their willingness to accept HIV testing [8], but
implementation of the PITC policy in the programme has never
been tested in India. To guide TB-HIV policy in India, we
prospectively evaluated the implementation of PITC in the
programme for all tuberculosis patients registered in two districts
in south India. The study objectives were to evaluate the feasibility
and effectiveness of PITC in detecting HIV-infection in TB
patients and to assess the efficiency of linkage to HIV care and
treatment for HIV infected TB patients.
Methods
Setting
The study was conducted in two districts: Mysore (population 2.8
million) in Karnataka state and Tiruchirappalli (population 2.5
million) in Tamil Nadu state. These districts have been classified as
high priority for HIV interventions by NACO on the basis of
consistently having .1% HIV seroprevalence during sentinel
surveillance at antenatal clinics [9]. In the two districts, RNTCP
services are available through a network of primary health care
facilities which provide general health services, including TB
diagnostic and treatment services. Tuberculosis services are
decentralized, with quality-assured smear microscopy and directly
observed treatment through all public health facilities and through a
network of community DOT providers. All TB patients initiated on
treatment were registered at the six sub district level TB programme
management units in each district. Voluntary HIV counselling and
testing services were offered through a NACP-supported network of
57 integrated counselling and testing centres (ICTC): 27 in Mysore
and 30 in Tiruchirappalli. Free antiretroviral treatment (ART) was
provided at two ART centres (1 in each district), where HIV-
infected patients are screened for ART eligibility and offered HIV
treatment and care. These service delivery sites under NACP
follow the national guidelines for counselling, testing, care and
treatment of HIV-infected patients [10].
Design and Definitions
A prospective observational study was undertaken after
introducing the PITC referral procedure for all the TB patients
registered under RNTCP from 1 July, 2007 to 31 March 2008 in
two districts of South India. The outcomes assessed were feasibility
of referral for HIV testing, its effectiveness in terms of
ascertainment of HIV status for TB patients and the initiation of
ART in HIV-infected TB patients. Known HIV status was defined
as HIV test result from an ICTC prior to TB diagnosis. A TB
patient was considered to be referred to an ICTC or ART centre if
the referral was documented on the TB treatment card, a referral
form, or the relevant register in the ICTC or ART centre. A
patient was presumed to have reached the ICTC or ART centre if
evidence of their visit was recorded in the corresponding registers
in the ICTC or ART centre.
PITC Implementation
Physicians and health staff were directed to assess all TB
patients for HIV status. If the patient’s HIV status was known, that
information was to be recorded on the modified treatment card. If
the HIV status was unknown, physicians were asked to advise the
patients to undergo voluntary HIV testing as soon as possible at
the ICTC in the same facility (if available) or at the nearest ICTC.
HIV testing was performed as per NACP guidelines which
includes verbal consent, pre- and post-test counselling for all
clients [10]. HIV test results were communicated by the
counsellors to the referring physician through patients and
directly, provided patients did not object to ensure timely care
and support to HIV infected patients.
Physicians were asked to refer HIV-infected TB patients to the
ART centre as soon as possible, after at least 2 weeks of anti-TB
treatment in order to reduce the risk of transmission to others.
Those patients already known to be HIV infected prior to TB
treatment were also referred to ART centres for modification of
their ART regimen. National ART guidelines recommend that
CD4 cell testing be performed at the initial evaluation in all clients,
and recommend ART for patients with pulmonary tuberculosis
having a CD4 count ,350/mm3 or all patients with any
extrapulmonary TB disease —who would be classified as WHO
clinical stage 4—regardless of CD4 count [11]. ART is to be
initiated as soon as possible if the CD4 count is ,200/mm3, or
soon after completion of the intensive phase of anti-TB treatment
if CD4 count was 200–350/mm3. ART centres were asked to send
TB patients back to the referring physician with feedback on the
initiation of ART.
To initiate implementation of PITC for TB patients, along with
district health authorities we held training sessions in the districts
for all public sector physicians, ICTC counsellors, NGO and
private sector partners participating in the programme, TB
programme staff, and ART centre staff. Training consisted of
PITC and ART referral procedures, recording requirements, and
the introduction and distribution of standardized referral forms for
ICTC and ART.
Data Collection and Analysis
Information was prospectively collected on all TB patients
registered from 1 July 2007 to 31 March 2008. Data sources were
routine records of RNTCP and NACP—specifically TB registers,
TB treatment cards, ICTC registers, ART centre records, and the
referral forms. Modified TB treatment cards were used to
document the information related to referrals and HIV status.
Trained field investigators visited all health facilities in the districts
at least monthly for data collection and for updating the
information and did not interfere in the referral procedure. Events
abstracted from relevant records included registration of a patient
in the TB register, initial ascertainment of HIV status, referral for
HIV testing, HIV test results, referral to ART centres, evaluation
for ART and initiation of ART as well as cotrimoxazole
prophylaxis. Periodically the study investigators cross verified the
data abstracted with that in the records available at the health
centres, ICTC and ART centres.
The abstracted data on the line list was double entered into EPI
info 6.04d (Centers for Disease Control and Prevention, Atlanta,
USA) and entries in the data base were validated by randomly
crosschecking with the abstracted data. Analysis was conducted
using SPSS 10.0 (SPSS Inc., Chicago, USA). Proportions were
compared by applying the x2 test or Fisher’s exact test if numbers
were small.
Ethics Statement
This evaluation assessed the feasibility and effectiveness of the
implementation of new policies and procedures for referral and
HIV testing of TB patients in the national programmes. Individual
informed verbal consent was taken for all HIV testing as per
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NACP guidelines, with pre-test counselling, and post-test coun-
selling by trained health care workers. Individual informed consent
for data abstraction from routine programme records was not
taken, as the collection of these data was considered by the
institutional ethics committees and the National TB and HIV/
AIDS Programmes to be a programme evaluation. Data
abstracted from programme records were securely held and
confidentially maintained by study staff. These procedures were
specifically approved by the respective ethics committees of the
National Tuberculosis Institute, Bangalore, and the Tuberculosis
Research Centre, Chennai. Approval for the research was granted
by the Ministry of Health and Family Welfare, Government of
India.
Results
Referral and HIV Testing of TB Patients
From July 2007 to March 2008, 5299 TB patients were
registered (Figure 1). Of these, 597 (11.3%) knew their HIV status
at the time of TB diagnosis. Among the remaining 4,701 TB
patients with unknown HIV status, 3,368 (71.6%) were referred
for HIV testing. Among those referred for HIV testing, the median
interval from the starting of TB treatment to referral for testing
was 8 days (25%–75% interquartile range 0–28 days). Within 2
weeks of starting TB treatment, 62% of TB patients with initially
unknown HIV status were referred for HIV testing. Of the 3,368
persons referred to the ICTC for HIV testing, 3,111 (92.4%) were
actually tested. There were no significant differences in the age or
sex distribution between those TB patients with unknown HIV
status and those who were HIV tested (data not shown).
In total, HIV status was ascertained for 3,705 (70%) of the 5,299
registered TB patients. There was no difference in the ascertain-
ment of HIV status between male or female TB patients (71% vs.
69%, p= 0.08), or between patients in Mysore or Tiruchirappalli
districts (69.5% and 70% respectively) (Table 1). The proportion
of persons with HIV status ascertained was lower in the young
(,14 years) and elderly (.55 years) age groups, relative to the
15–55 age group (64% vs. 72%, p,0.01); however, within each
age group, no significant differences were observed between males
and females.
HIV Prevalence among TB Patients
The overall prevalence of HIV infection among the 5299
registered TB patients was 468 (8.8%). This includes 268 (5.1%)
who were known HIV-positive prior to TB diagnosis, and an
additional 200 (3.8%) detected after TB diagnosis. Male TB
patients were more likely to be HIV-infected than females (9.9%
vs. 6.8%, relative risk [RR] 1.5, 95% confidence interval [CI]
1.2–1.8). Although HIV infection was detected in all age groups,
HIV seroprevalence was highest in the 35–44 year age group both
among males (19.7%) and females (13.5%) (Table 1).
Characteristics of HIV-Infected TB Patients
Of the 468 HIV-infected patients, 268 (57%) had HIV
diagnostic dates reported before TB diagnostic dates (Table 2).
Among the 200 patients diagnosed with HIV on the day of or after
their TB treatment initiation, the median time from TB treatment
initiation to HIV diagnosis was 12 days (interquartile range 0–18
days). Among the 468 patients, 296 (63%) had pulmonary TB, and
of these 107 (36%) were sputum smear-positive for acid-fast bacilli.
Provision of Anti-Retroviral Treatment
Of the 468 HIV-infected TB patients, 72 (15.4%) were already
on ART prior to TB diagnosis. Among the remaining 396 patients
not yet on ART at the time of TB diagnosis, we documented that
269 (68%) were referred and 220 (56%) reached the ART centre
(Figure 2). Of those who reached the ART centre, 105 (48%)
started ART during TB treatment. In total, 177 (37%) out of 468
HIV-infected patients were documented to have received any
ART during TB treatment. Cotrimoxazole prophylactic treatment
provision was documented in 64 (15%) of the 468 patients.
CD4 cell count information was available for 112 (51%) of the
220 who reached the ART centre (Figure 2). Among the 112 with
CD4 results available, 93 (83%) had a CD4 count,350/mm3 and
were eligible for ART under NACO guidelines. Among the 74
patients documented to have a CD4 cell count of ,200/mm3,
ART was initiated in 51 (69%). Of the 19 with a CD4 cell count
201–350/mm3, ART was initiated in 7 (37%). The non
availability of CD4 count information for 108 patients was
unexpected and unexplained, as usually CD4 testing is conducted
upon initial pre- registration at ART centres.
Case Notification Before and After Initiation of PITC
Total TB case notification per 100,000 population for the
period before and after the initiation of PITC is shown in
Figure 3. No changes were noted in TB case-finding indicators
after PITC implementation. The mean number of persons
examined by smear microscopy was not different. The mean
quarterly total TB case notification rate for 1.5 years prior to
PITC implementation (January 2006 to June 2007) was 32 per
100,000 population; after PITC implementation (July 2007–
March 2008), total TB case notification was 33 per 100,000
population.
Discussion
This is the first study to provide tangible evidence from India of
successful and timely implementation of PITC in TB patients
Figure 1. HIV referral and testing outcomes of RNTCP-
registered TB patients, Mysore and Tiruchirappalli Districts,
July 2007–March 2008.
doi:10.1371/journal.pone.0007899.g001
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through general health services in settings with high HIV
prevalence. It also underscores the need for strengthening the
uptake of ART services in such settings. In two districts, where
HIV testing services were decentralized to a similar extent as TB
services, half of TB patients with initially unknown HIV status
were referred for HIV testing within 8 days of TB treatment
initiation. This suggests that referrals for HIV testing were
efficiently conducted, as would be necessary for patients to benefit
from early HIV detection and treatment. After PITC policy
implementation, HIV status was ascertained for 70% of TB
patients, including 3108 TB patients (59%) who had previously
unknown HIV status; 200 (3.8%) of TB patients were newly-
detected as HIV infected. HIV status was ascertained most
efficiently among adults aged 15–54 years, and with similar
efficiency between males and females. Effective implementation of
PITC for TB patients has been reported from other countries,
including Thailand, South Africa and Kenya [12,13,14]. Earlier
studies from India and Ethiopia warned of a possible gap between
initial willingness for HIV screening and actual attendance at
ICTC for testing [8,15]. In this cohort, however, we observed that
92% of those referred for testing actually underwent HIV testing.
We furthermore observed no effect of PITC implementation on
TB case finding indicators, suggesting that apprehension of
adverse effects on TB programme performance was unfounded.
Although HIV testing was reasonably efficient, the HIV status
of 30% of TB patients still remained unknown, primarily
attributable to lack of referral or incomplete documentation.
Interviews of randomly selected patients from the same cohort,
however, found that 80% of TB patients reported referral for HIV
testing (submitted for publication manuscript No. 09-PONE-RA-
13100). The probable reason for the discrepancy could be the gap
in documentation of referral-related data on the programme
records. These findings call for increasing the awareness among
patients as well as health care providers about the high burden of
HIV in TB patients and the advantages of early detection of HIV
in conjunction with care and support services. Nursing and
ancillary paramedical staffs at health facilities often have frequent
contact and excellent rapport with patients, and are essential for
maintaining accurate medical records. Greater involvement of
ancillary health staff in referrals and documentation of results may
enhance the efficiency of referrals as well as improve the quality of
recording.
Although the two districts studied were considered to have high
HIV prevalence on the basis of historical antenatal HIV
surveillance results, the prevalence of HIV among adult TB
patients was still somewhat surprising. HIV prevalence among TB
patients was 8.8% overall, but among male TB patients aged
25–44 years, it was 18% or, more than 1 in 6 were HIV-infected.
Male TB patients were 1.4 times more likely to be HIV-infected
than female TB patients, consistent with the sex difference
reported in national surveillance and the distribution of HIV in
the general population [16]. While HIV infection among TB
patients can occur at any age and was observed in all age groups in
this population, the particularly high HIV seroprevalence among
adult TB patients could be stressed in the message given by the
provider to promote HIV testing.
The potential benefits of efficient detection of HIV infection
among TB patients were unfortunately not effectively realized in
these settings; of the 396 HIV-infected TB patients who were not
already on ART, only 105 (27%) received any ART. The failure to
efficiently provide ART to HIV-infected TB patients has also been
reported from Thailand, Kenya and Malawi [17,18,19]. Even
among TB patients with a documented CD4 count of ,350/mm3
and eligible for ART as per NACP guidelines, only 62% actually
received ART. We speculate that the provision of ART from a
single center situated in a tertiary care setting in each of the two
Table 1. Diagnosis of HIV among TB patients, Mysore and Tiruchirappalli, July 2007–March 2008.
Category Subcategory Registered N=5299 HIV status ascertained (%)* HIV-positive (%)*
District of Residence Mysore 2,796 1,946 (69.5) 193 (6.9)
Tiruchirappalli 2,503 1,763 (70.4) 275 (10.9)
Males Total 3,464{ 2,452{(71) 344 (9.9)
0–14 years 196 113 (58) 10 (5.1)
15–24 years 429 311 (73) 7 (1.6)
25–34 years 596 439 (74) 98 (16.4)
35–44 years 763 552 (72) 150 (19.7)
45–54 years 657 476 (72) 52 (7.9)
55–64 years 502 360 (72) 19 (3.8)
$65 years 319 200 (63) 7 (2.2)
Females Total 1,835 1,257 (69) 124 (6.8)
0–14 years 147 76 (52) 3 (2.0)
15–24 years 508 363 (72) 6 (1.2)
25–34 years 410 294 (72) 47 (11.5)
35–44 years 326 235 (72) 44 (13.5)
45–54 years 226 156 (69) 18 (8.0)
55–64 years 149 91 (61) 6 (4.0)
$65 years 69 42 (61) 0
*Denominator for percentage is the number of registered TB patients in each subcategory.
{Age for 2 patients not available.
{Age for 1 patient not available.
doi:10.1371/journal.pone.0007899.t001
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districts may be an important factor contributing to the limited
ART uptake we observed. Operational research to understand
weaknesses in the ART referral, evaluation, and initiation process
at NACP ART centres is urgently needed.
Limitations
As a programme evaluation this study was subject to some
limitations. There were no control areas for comparison for the
proportion of HIV-tested TB patients, as our intent was to
establish the feasibility and effectiveness of PITC implementation
under programme conditions across all general health facilities in
both districts. We chose to contrast our observations relative to the
larger target of HIV-testing for all TB patients in high HIV
prevalence areas [7,20]. We were not able to collect information
Figures 2. Referral of HIV-infected TB patients to ART centres, and initiation of ART during TB treatment by CD4 cell count, Mysore
and Tiruchirappalli Districts, July 2007–March 2008.
doi:10.1371/journal.pone.0007899.g002
Figure 3. Number of persons examined by sputum smear
microscopy, and number of notified tuberculosis cases, Mysore
and Tiruchirappalli District, January 2006–December 2008.
doi:10.1371/journal.pone.0007899.g003
Table 2. Characteristics of HIV-infected TB patients, Mysore
and Tiruchirappalli, July 2007–March 2008, N = 468.
Category Subcategory Number (%)
Type of TB (n = 468) Pulmonary 296 (63)
Extra pulmonary 172 (37)
Type of Pulmonary TB (n=296) New smear-positive 107 (36)
New smear-negative 153 (52)
Retreatment smear-positive 28 (9)
Retreatment smear-negative 8(3)
Pulmonary smear status (n=296) Total smear-positive 135 (46)
Total smear-negative 161 (54)
Time of HIV diagnosis (n = 468) Prior to TB diagnosis 268 (57)
After TB diagnosis 200 (43)
Time to HIV diagnosis (n=200*) Mean 12 days
Interquartile Range (25–75%) 0–18 days
CD4 cell count (n = 468) CD4 count ,200/mm3 99 (21)
CD4 count 201–350/mm3 24 (5)
CD4 count .350/mm3 23 (5)
CD4 count not available 146 (31)
Not referred / not reached ART 176(38)
CPT provision (n = 468) Yes 64 (14)
No information 404 (86)
ART initiation (n = 468) Before TB diagnosis 72 (15)
After TB diagnosis 61 (13)
No ART documented 335 (72)
*Among those persons with HIV diagnosis after TB diagnosis.
doi:10.1371/journal.pone.0007899.t002
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on reasons for non-referral or failure to complete referrals for HIV
testing, but a parallel study with patient interviews to address these
questions from the patients’ perspective has been conducted
(submitted for publication, manuscript number 09-PONE-RA-
13100). The rates of referrals, completion of HIV testing, and
ART initiation, we report may underestimate what actually
happened to these patients, as we depended on the ongoing
process of recording the activities by providers which was updated
till November 2008. We sought, however, to minimize the effect of
non-recording by collecting information on each process from
multiple data sources.
As the study was done under programme conditions, we only
captured information on HIV testing done at NACP ICTCs and
treatment provided from NACP ART centre, though HIV testing
and ART is also available from the private sector. As per policy,
however, persons with HIV test results from private laboratories
were regardless referred to ICTCs for HIV counselling and testing
on the premise that patients would benefit from counselling as well
as confirmation of HIV status with quality-assured tests. Our
information on CPT was limited to prescription from the NACP
ART centre. We had limited information on CD4 results, due to
recording challenges at the ART centre or patients not reporting
back to ART centers due to multiple visits required for evaluation.
Most patients who reached the ART centre would have a CD4 test
done, hence—with half the CD4 information missing—our results
regarding ART initiation across different levels of immune
deficiency should be interpreted with caution. We could not assess
the effect of bias due to under-reporting.
Translating Research Findings into Policy and Practice
These results were considered by the National Programmes to
be reasonably applicable to settings with higher HIV burdens,
particularly since PITC was implemented by existing health staff
with routine programme recording and reporting. We did provide
additional training support as an external input, but training and
supervision would normally be the role of the national Pro-
grammes. Also, HIV diagnostic care and treatment services under
NACP are undergoing extensive expansion and decentralization,
which would further improve opportunities for HIV diagnosis for
TB patients and subsequent linkage to ART.
Based on these encouraging findings, PITC for TB patients has
been incorporated into policy and practice in higher HIV burden
settings in India [21]. To improve efficiency of HIV testing and
the delivery of HIV treatment to HIV-infected TB patients,
training on TB-HIV activities is being conducted for medical and
paramedical staff throughout the general health system, with
special emphasis on states with the highest HIV burden. Routine
TB programme records have been altered to allow the recording
of HIV status and links to care. RNTCP has begun routinely
monitoring and publicly reporting on the proportion of TB
patients with HIV status ascertained, the proportion HIV-infected,
and the proportion of HIV-infected TB patients provided with
ART and CPT [22].
Conclusion
The implementation of PITC for TB patients is feasible in the
general health care system of high HIV prevalence settings in
India, and can efficiently identify HIV-infected TB patients.
Concerns that PITC for TB patients might adversely affect TB
case notification appear to have been unfounded. Our observa-
tion, however, of low ART uptake strongly underscores the
importance of expanding and improving the delivery of treatment
services for HIV-infected patients. Creating and enhancing
awareness among providers and patients regarding the benefits
of early diagnosis of HIV, along with benefits of care and support
is essential.
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